140 related articles for article (PubMed ID: 24974678)
1. Laboratory diagnosis of Lyme borreliosis in Scottish patients: a novel approach.
Mavin S; Watson EJ; Evans R
Br J Biomed Sci; 2014; 71(2):51-4. PubMed ID: 24974678
[TBL] [Abstract][Full Text] [Related]
2. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
3. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
[TBL] [Abstract][Full Text] [Related]
4. C6 peptide enzyme immunoassay in Lyme borreliosis serology.
Rouhiainen M; Pietikäinen A; Kortela E; Kanerva MJ; Oksi J; Hytönen J
J Microbiol Methods; 2021 Jan; 180():106122. PubMed ID: 33326821
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
[TBL] [Abstract][Full Text] [Related]
6. The use of local isolates in Western blots improves serological diagnosis of Lyme disease in Scotland.
Mavin S; Milner RM; Evans R; Chatterton JMW; Joss AWL; Ho-Yen DO
J Med Microbiol; 2007 Jan; 56(Pt 1):47-51. PubMed ID: 17172516
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.
Lipsett SC; Branda JA; McAdam AJ; Vernacchio L; Gordon CD; Gordon CR; Nigrovic LE
Clin Infect Dis; 2016 Oct; 63(7):922-8. PubMed ID: 27358358
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
9. [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis].
Zajkowska J; Kondrusik M; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T; Czeczuga A; Sienkiewicz I
Przegl Epidemiol; 2006; 60 Suppl 1():177-85. PubMed ID: 16909799
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
[TBL] [Abstract][Full Text] [Related]
12. The development of an IgG avidity Western blot with potential to differentiate patients with active Lyme borreliosis from those with past infection.
Mavin S; Evans R; Cornulier T; Bowman AS
J Microbiol Methods; 2018 Mar; 146():71-76. PubMed ID: 29421691
[TBL] [Abstract][Full Text] [Related]
13. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fifteen commercially available serological tests for diagnosis of Lyme borreliosis.
Goossens HA; van den Bogaard AE; Nohlmans MK
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):551-60. PubMed ID: 10517192
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies against Borrelia afzelii, Borrelia burgdorferi sensu stricto and the 41-kiloDalton flagellin in patients from a Lyme borreliosis endemic area: analysis by EIA and immunoblot.
Nilsson I; von Rosen IA
APMIS; 1996 Dec; 104(12):907-14. PubMed ID: 9048870
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Lyme borreliosis using enzyme immunoanalysis.
Cermakova Z; Ryskova O; Honegr K; Cermakova E; Hanovcova I
Med Sci Monit; 2005 Apr; 11(4):BR121-5. PubMed ID: 15795690
[TBL] [Abstract][Full Text] [Related]
17. Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
Porwancher R; Landsberg L
PLoS One; 2021; 16(9):e0253514. PubMed ID: 34499659
[TBL] [Abstract][Full Text] [Related]
18. C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.
Pomelova VG; Korenberg EI; Kuznetsova TI; Bychenkova TA; Bekman NI; Osin NS
PLoS One; 2015; 10(7):e0130048. PubMed ID: 26147441
[TBL] [Abstract][Full Text] [Related]
19. More specific bands in the IgG western blot in sera from Scottish patients with suspected Lyme borreliosis.
Evans R; Mavin S; McDonagh S; Chatterton JM; Milner R; Ho-Yen DO
J Clin Pathol; 2010 Aug; 63(8):719-21. PubMed ID: 20595179
[TBL] [Abstract][Full Text] [Related]
20. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.
Peltomaa M; McHugh G; Steere AC
Otol Neurotol; 2004 Sep; 25(5):838-41. PubMed ID: 15354020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
